ClinicalTrials.gg
RecruitingNCT07847840Updated Nov 18, 2026

Effect of the Dietary Supplement to Alleviate Dry Mouth.

An interventional study of Dietary Supplement in Xerostomia, sponsored by Lacer S.A.. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Lacer S.A. (part of Italfarmaco) · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 18, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 19 studies in Xerostomia with a site in Spain — 4 open to participants now, 6 under way, none of them phase 3. Xerostomia · Spain.

Planned enrollment
14th of 18
35 · median 47
Started
2026
with 1 other
No phase
12 of 19
4 open now
Registered
19th of 19
by date
Lead sponsor
1 of 19
Lacer S.A.

Among the 19 studies in Xerostomia with a site in Spain, this one is the 14th largest by planned enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2026, is one of 12 with no phase, and was the 19th registered.

Xerostomia

286 studies on the registry are indexed under Xerostomia; 50 are open to participants now.

Browse Xerostomia studies →

Open to participants now

4 of the 19 studies in Xerostomia with a site in Spain are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 26 Xerostomia studies recruiting now, 15 (58%) set no upper age limit and 7 (27%) stop at 75 or younger; 2 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Xerostomia with a site in Spain, or all of them as a file.
02

Study summary

The goal of this study is to learn if dietary supplement works to improve dry mouth in adults. The main question it aims to answer is:

  • Does dietary supplement reduce dry mouth sensation in subjects with dry mouth?

Participants will:

  • Take dietary supplement every day for 7 days
  • Visit the pharmacy at the beginning and the end of the study
03

Conditions studied

  • Xerostomia

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • Presence of subjective xerostomia.
  • Score ≥4 on the Numerical Rating Scale for Dryness (NRS, 0-10), established as the cut-off point for xerostomia.
  • Result consistent with xerostomia on the Fox Questionnaire.
  • Provision of written .

Exclusion criteria

Exclusion Criteria:

  • Inability to understand or complete the study questionnaires.
  • Recent initiation of a specific treatment for xerostomia that may interfere with the evaluation.
  • Presence of clinical conditions that, in the investigator's judgment, may interfere with the assessment of the study outcomes.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    Dietary supplement

    Dietary supplement will be taken daily for 7 days

    Dietary Supplement: Dietary Supplement

Interventions

  • Dietary supplementDietary Supplement

    Dietary supplement will be taken daily for 7 days

06

What researchers measure

Primary outcomes

  1. Change from Baseline in the dry mouth intensity at 7 days

    The dry mouth sensation will be evaluated by numeric dryness scale from 0 (no dryness) to 10 (maximum dryness imaginable).

    Time frame: From enrollment to the end of the study at 7 days

07

Study locations

1 of 1 sites recruiting
  • Farmacia Marqueta
    Barcelona, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Only data included in the publication will be shared.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 103 interventional studies with no phase under Xerostomia, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartActual
Oct 5, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Farmacia Marqueta is now Recruiting
Nov 18, 2026
Registered
First appeared on the registry
Sep 29, 2026
Show all 2 updates
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Farmacia Marqueta is now Recruiting
    + 1 other change: date precision
  2. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07847840
Lead sponsor
Lacer S.A.
Responsible party
Sponsor
First posted
Sep 29, 2026
Start date
Oct 5, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 18, 2026

Study contacts

Garcia
Contact
daniella@recerca.com
34 682319930

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion